Protocol # 16-001:A 12-Month Double-Blind, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Efficacy of Endoluminal Aluvra™ for the Treatment of Gastroesophageal Reflux Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date2/6/18 → 2/6/21

Funding

  • Impleo Medical, Inc. (Protocol #16-001)